Parkman Healthcare Partners’s SI-BONE Inc SIBN Stock Holding History

Parkman Healthcare Partners’s Portfolio SIBN Stock Details SIBN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.72M	Sell	373,553 -829	-0.2%	-$13K	0.49%	60
2025 Q4	$7.38M	Sell	374,382 -4,201	-1%	-$73K	0.7%	46
2025 Q3	$5.57M	Buy	378,583 +16,575	+5%	+$271K	0.58%	62
2025 Q2	$6.81M	Buy	362,008 +130,899	+57%	+$2.17M	0.78%	51
2025 Q1	$3.24M	Buy	231,109 +14,509	+7%	+$234K	0.38%	62
2024 Q4	$3.04M	Buy	216,600 +31,284	+17%	+$421K	0.4%	61
2024 Q3	$2.59M	Buy	185,316 +32,301	+21%	+$486K	0.33%	67
2024 Q2	$1.98M	Buy	153,015 +234	+0.2%	+$3.34K	0.27%	74
2024 Q1	$2.5M	Buy	152,781 +7,206	+5%	+$136K	0.31%	78
2023 Q4	$3.06M	Sell	145,575 -9,471	-6%	-$175K	0.43%	67
2023 Q3	$3.29M	Buy	155,046 +16,131	+12%	+$374K	0.6%	48
2023 Q2	$3.75M	Buy	+138,915	New	+$3.39M	0.65%	49

Other funds holding SIBN

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Parkman Healthcare Partners's SIBN Position: Q1 2026 in Review

Parkman Healthcare Partners reduced its SI-BONE Inc (SIBN) stake by 0.22% in Q1 2026, selling an estimated $13K and leaving 373,553 shares worth $4.72M. The position accounts for 0.49% of the portfolio, ranked #60.

Parkman Healthcare Partners first reported a position in SIBN in Q2 2023 and has held it in 12 quarters since. The position peaked at $7.38M in Q4 2025. 180 funds tracked by Wall St. Rank hold SIBN as of Q1 2026.

Parkman Healthcare Partners held 373,553 shares of SI-BONE Inc worth $4.72M as of Q1 2026.
Parkman Healthcare Partners sold 829 SI-BONE Inc shares in Q1 2026, an estimated $13K.
SI-BONE Inc made up 0.49% of Parkman Healthcare Partners's portfolio in Q1 2026, its #60 holding.
Parkman Healthcare Partners first reported a position in SI-BONE Inc in Q2 2023 and has held it in 12 quarters since.
Parkman Healthcare Partners's SI-BONE Inc position peaked at $7.38M in Q4 2025.
180 funds tracked by Wall St. Rank held SI-BONE Inc as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.